SPC
SRNE

Sigma Planning Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sigma Planning Corp’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 1513
2021
Q4 		– Sell
-14,440
Closed -$89.6K – 1500
2021
Q3 		$110K Buy
14,440
+1,110
+8% +$9.41K ﹤0.01% 1310
2021
Q2 		$129K Sell
13,330
-2,050
-13% -$16.3K ﹤0.01% 1344
2021
Q1 		$127K Buy
15,380
+3,930
+34% +$41.5K ﹤0.01% 1270
2020
Q4 		$78K Sell
11,450
-8,160
-42% -$65.5K ﹤0.01% 1164
2020
Q3 		$219K Buy
+19,610
New +$179K 0.01% 920
2019
Q3 		– Sell
-41,500
Closed -$111K – 1086
2019
Q2 		$111K Buy
41,500
+1,000
+2% +$3.6K 0.01% 953
2019
Q1 		$192K Buy
40,500
+20,250
+100% +$53.1K 0.01% 858
2018
Q4 		$49K Buy
20,250
+1,000
+5% +$3.27K ﹤0.01% 835
2018
Q3 		$85K Hold
19,250
– – 0.01% 925
2018
Q2 		$139K Buy
19,250
+4,750
+33% +$32.3K 0.01% 856
2018
Q1 		$75K Buy
+14,500
New +$103K 0.01% 835

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return